Showing results (1491-1500 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|February 25, 2015
Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and olderAmy Lanteigne, Yi-Han Sheu, Til Stürmer, et al.CNS Drugs|July 28, 2012
Transdermal granisetron: a guide to its use in preventing nausea and vomiting induced by chemotherapyGillian M Keating, Sean T Duggan, Monique P CurranCNS Drugs|August 30, 2012
Oromucosal midazolam: a guide to its use in paediatric patients with prolonged acute convulsive seizuresLesley J Scott, Katherine A Lyseng-Williamson, Karly P Garnock-JonesCNS Drugs|July 13, 2012
Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxietyJuan-Antonio Micó, Rita PrietoCNS Drugs|July 13, 2012
The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidenceGabriele Sani, Giulia Serra, Giorgio D Kotzalidis, et al.CNS Drugs|June 27, 2012
Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover studyDaniel M Hartung, Luke Middleton, Leanne Svoboda, et al.CNS Drugs|June 21, 2012
Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature reviewEric Q Wu, Paul Hodgkins, Rym Ben-Hamadi, et al.CNS Drugs|June 21, 2012
Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western AustraliaLyn Colvin, Linda Slack-Smith, Fiona J Stanley, et al.CNS Drugs|January 22, 2010
Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's diseaseAngelo Antonini, K Ray Chaudhuri, Pablo Martinez-Martin, et al.CNS Drugs|January 22, 2010
Therapeutic options for treatment-resistant depressionRichard C Shelton, Olawale Osuntokun, Alexandra N Heinloth, et al.Pageof 211